RESTORE IMMUNE COMPETENCE AGAINST CANCER CELLS IN RENAL CELL CARCINOMA RESISTANT TO STANDARD TREATMENTS TRANSLATE – kidney STUDY
Latest Information Update: 11 Oct 2021
At a glance
- Drugs Aldesleukin (Primary) ; Cyclophosphamide (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms TRANSLATE-KIDNEY; TRANSLATE-RE
- 11 Oct 2021 New trial record